Bagan L, Ocete-Monchon MD, Leopoldo-Rodado M, Murillo-Cortes J, Daz-Fernndez JM, Medina-Gonzalez R, Gimeno-Cardona C, Bagan JV. Prevalence of salivary epstein-barr virus in potentially malignantoral disorders and oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2016 Mar 1;21 (2):e157-60. 

 

 

doi:10.4317/medoral.20785

http://dx.doi.org/doi:10.4317/medoral.20785

 

 

1. Tugizov SM, Herrera R, Palefsky JM. Epstein-Barr virus transcytosis through polarized oral epithelial cells. J Virol. 2013;87:8179-94.
http://dx.doi.org/10.1128/JVI.00443-13

 

2. Ueda S, Uchiyama S, Azzi T, Gysin C, Berger C, Bernasconi M, et al. Oropharyngeal group A streptococcal colonization disrupts latent Epstein-Barr virus infection. J Infect Dis. 2014;209:255-64.
http://dx.doi.org/10.1093/infdis/jit428

 

3. de Frana TR, de Albuquerque Tavares Carvalho A, Gomes VB, Gueiros LA, Porter SR, Leao JC. Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1. Clin Oral Investig. 2012;16:659-64.
http://dx.doi.org/10.1007/s00784-011-0548-5

 

4. Shan J, Pow EH, Tsang PC, Perera RA, Kwong DL. Comparison of two laboratory extraction techniques for the detection of Epstein-Barr virus in the saliva of nasopharyngeal carcinoma patients. J Investig Clin Dent. 2014;5:104-8.
http://dx.doi.org/10.1111/jicd.12078

 

5. Grande SR, Imbronito AV, Okuda OS, Pannuti CM, Nunes FD, Lima LA. Relationship between herpesviruses and periodontopathogens in patients with HIV and periodontitis. J Periodontol. 2011;82:1442-52.
http://dx.doi.org/10.1902/jop.2011.100723

 

6. Sahin S, Saygun I, Kubar A, Slots J. Periodontitis lesions are the main source of salivary cytomegalovirus. Oral Microbiol Immunol. 2009;24:340-2.
http://dx.doi.org/10.1111/j.1399-302X.2009.00528.x

 

7. Dawson DR, Wang C, Danaher RJ, Lin Y, Kryscio RJ, Jacob RJ, et al. Salivary levels of Epstein-Barr virus DNA correlate with subgingival levels, not severity of periodontitis. Oral Dis. 2009;15:554-9.
http://dx.doi.org/10.1111/j.1601-0825.2009.01585.x

 

8. Slots J, Saygun I, Sabeti M, Kubar A. Epstein-Barr virus in oral diseases. J Periodontal Res. 2006;41:235-44.
http://dx.doi.org/10.1111/j.1600-0765.2006.00865.x

 

9. Bilder L, Elimelech R, Szwarcwort-Cohen M, Kra-Oz Z, Machtei EE. The prevalence of human herpes viruses in the saliva of chronic periodontitis patients compared to oral health providers and healthy controls. Arch Virol. 2013;158:1221-6.
http://dx.doi.org/10.1007/s00705-013-1609-7

 

10. Bagan JV, Jimnez Y, Murillo J, Poveda R, Daz JM, Gavald C, et al. Epstein-Barr virus in oral proliferative verrucous leukoplakia and squamous cell carcinoma: A preliminary study. Med Oral Patol Oral Cir Bucal. 2008;13:E110-3.

 

11. Carrard VC, Brouns ER, van der Waal I. Proliferative verrucous leukoplakia; a critical appraisal of the diagnostic criteria. Med Oral Patol Oral Cir Bucal. 2013;18:e411-3.
http://dx.doi.org/10.4317/medoral.18912

 

12. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993;694:72-7.
http://dx.doi.org/10.1111/j.1749-6632.1993.tb18343.x

 

13. Kuhara T, Watanabe D, Ishida N, Tamada Y, Matsumoto Y, Ihira M, et al. Quantitative analysis of shedding of Epstein-Barr virus in saliva from patients with connective tissue diseases: a pilot study. Int J Dermatol. 2013;52:887-90.
http://dx.doi.org/10.1111/j.1365-4632.2011.04992.x

 

14. Descamps V, Avenel-Audran M, Valeyrie-Allanore L, Bensaid B, Barbaud A, AlJawhari M, et al. French Study Group of Cutaneous Drug Adverse Reactions. Saliva polymerase chain reaction assay for detection and follow-up of herpesvirus reactivation in patients with drug reaction with eosinophilia and systemic symptoms (DRESS). JAMA Dermatol. 2013;149:565-9.
http://dx.doi.org/10.1001/jamadermatol.2013.2018

 

15. Verdugo F, Castillo A, Castillo F, Uribarri A. Epstein-Barr virus associated peri-implantitis: a split-mouth study. Clin Oral Investig. 2015;19:535-43.
http://dx.doi.org/10.1007/s00784-014-1250-1

 

16. Amornthatree K, Sriplung H, Mitarnun W, Nittayananta W. Effects of long-term use of antiretroviral therapy on the prevalence of oral Epstein-Barr virus. J Oral Pathol Med. 2012;41:249-54.
http://dx.doi.org/10.1111/j.1600-0714.2011.01089.x

 

17. Nikoobakht M, Beitollahi J, Nikoobakht N, Aloosh M, Sahebjamee M, Rezaeidanesh M, et al. Evaluation of Epstein-Barr virus load in saliva before and after renal transplantation. Transplant Proc. 2011;43:540-2.
http://dx.doi.org/10.1016/j.transproceed.2011.01.004

 

18. Pow EH, Law MY, Tsang PC, Perera RA, Kwong DL. Salivary Epstein-Barr virus DNA level in patients with nasopharyngeal carcinoma following radiotherapy. Oral Oncol. 2011;47:879-82.
http://dx.doi.org/10.1016/j.oraloncology.2011.06.507

 

19. Acharya S, Ekalaksananan T, Vatanasapt P, Loyha K, Phusingha P, Promthet S, et al. Association of Epstein-Barr virus infection with oral squamous cell carcinoma in a case-control study. J Oral Pathol Med. 2015;44:252-7.
http://dx.doi.org/10.1111/jop.12231

 

20. Jiang R, Ekshyyan O, Moore-Medlin T, Rong X, Nathan S, Gu X, et al. Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis. J Oral Pathol Med. 2015;44:28-36.
http://dx.doi.org/10.1111/jop.12221

 

21. Sand L, Jalouli J. Viruses and oral cancer. Is there a link? Microbes Infect. 2014;16:371-8.
http://dx.doi.org/10.1016/j.micinf.2014.02.009

 

22. Nasher AT, Al-Hebshi NN, Al-Moayad EE, Suleiman AM. Viral infection and oral habits as risk factors for oral squamous cell carcinoma in Yemen: a case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:566-72.
http://dx.doi.org/10.1016/j.oooo.2014.08.005

 

23. Saravani S, Miri-Moghaddam E, Sanadgol N, Kadeh H, Nazeri MR. Human herpesvirus-6 and epstein-barr virus infections at different histopathological grades of oral squamous cell carcinomas. Int J Prev Med. 2014;5:1231-8.